Clinical Trial Update: Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 clinical trial of ZG006 for Small cell lung cancer and neuroendocrine carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Carcinoma
• Small Cell Lung Cancer

Drugs mentioned

• ZG006

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Small Cell Lung Cancer, Neuroendocrine Carcinoma | Phase 1, Phase 2 | Status: RECRUITING